We are live on ! Find out more
MD icon

Pediatrix Medical

214 hedge funds and large institutions have $1.25B invested in Pediatrix Medical in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

2% more funds holding

Funds holding: 209214 (+5)

4% more capital invested

Capital invested by funds: $1.2B → $1.25B (+$47.7M)

0.67% less ownership

Funds ownership: 101.56%100.88% (-0.67%)

58% less call options, than puts

Call options by funds: $684K | Put options by funds: $1.62M

Holders
214
Holders Change
+5
Holders Change %
+2.39%
% of All Funds
3.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
90
Reduced
58
Closed
28
Calls
$684K
Puts
$1.62M
Net Calls
-$932K
Net Calls Change
-$1.09M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$201M -$2.8M -184,746 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$148M +$3.16M +208,617 +2%
Lazard Asset Management
3
Lazard Asset Management
New York
$121M +$17.4M +1,148,296 +16%
AllianceBernstein
4
AllianceBernstein
Tennessee
$118M +$22.1M +1,459,678 +23%
EARNEST Partners
5
EARNEST Partners
Georgia
$97.8M +$162K +10,666 +0.2%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$57.6M +$4.64M +306,469 +9%
State Street
7
State Street
Massachusetts
$51M -$804K -53,048 -2%
ACH
8
ArrowMark Colorado Holdings
Colorado
$39.3M -$21.4M -1,410,256 -35%
RRAM
9
River Road Asset Management
Kentucky
$23.8M -$11.3M -744,334 -32%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$23.1M +$928K +61,284 +4%
New York State Common Retirement Fund
11
New York State Common Retirement Fund
New York
$22.4M -$757K -49,991 -3%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$21.2M +$6.32M +417,317 +42%
Charles Schwab
13
Charles Schwab
California
$20.7M +$916K +60,461 +5%
Morgan Stanley
14
Morgan Stanley
New York
$12.5M +$408K +26,942 +3%
Northern Trust
15
Northern Trust
Illinois
$12.5M +$170K +11,201 +1%
Pacer Advisors
16
Pacer Advisors
Pennsylvania
$12.4M +$12.6M +834,279 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$12.1M -$390K -25,750 -3%
ACB
18
Aristotle Capital Boston
Massachusetts
$12.1M +$878K +57,935 +8%
SBH
19
Segall Bryant & Hamill
Illinois
$12M -$169K -11,184 -1%
PCM
20
Palisade Capital Management
New Jersey
$11.5M +$454K +29,991 +4%
Citadel Advisors
21
Citadel Advisors
Florida
$11.5M +$5.17M +340,970 +79%
Norges Bank
22
Norges Bank
Norway
$10.7M -$433K -28,571 -4%
Invesco
23
Invesco
Georgia
$10.4M +$3.14M +206,984 +42%
Allianz Asset Management
24
Allianz Asset Management
Germany
$8.52M +$1.61M +106,600 +23%
Principal Financial Group
25
Principal Financial Group
Iowa
$7.54M -$123K -8,137 -2%

MD Hedge Fund Activity: Q1 2023 in Review

214 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2023, worth a combined $1.25B — up 4% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 28 closed out — a net gain of 7 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $22.1M. The largest seller was Starboard Value, exiting entirely with an estimated $81.3M sold.

  • 214 institutional investors held Pediatrix Medical (MD) as of Q1 2023, up from 209 in Q4 2022.
  • Funds reported $1.25B of Pediatrix Medical stock for Q1 2023, up 4% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q1 2023 and 28 closed out, a net change of +7 holders.
  • The largest Pediatrix Medical buyer in Q1 2023 was AllianceBernstein, an estimated $22.1M added.
  • The largest Pediatrix Medical seller in Q1 2023 was Starboard Value, an estimated $81.3M sold.

Based on aggregated 13F filings for Q1 2023.